[Modern trends in substitutive estrogen therapy in the postmenopausal period. B. Results of the use of an estro-progestogenic association].
D000328:Adult; D001161:Arteriosclerosis / Q000517:prevention & control*; D001284:Atrophy; D003327:Coronary Disease / Q000517:prevention & control*; D004967:Estrogens / Q000627:therapeutic use*; D004997:Ethinyl Estradiol / Q000627:therapeutic use*; D005260:Female; D005831:Genital Diseases, Female / Q000517:prevention & control*; D006801:Humans; D006937:Hypercholesterolemia / Q000517:prevention & control*; D008593:Menopause; D001523:Mental Disorders / Q000517:prevention & control*; D008875:Middle Aged; D010024:Osteoporosis / Q000517:prevention & control*; D011372:Progestins / Q000627:therapeutic use*; D012871:Skin Diseases / Q000517:prevention & control*
D004967:Estrogens; D011372:Progestins; D004997:Ethinyl Estradiol
Moderni orientamenti in tema di estrogenoterapia sostitutiva nella postmenopausa. B. Risultati dell'impiego di una associazione estro-progestinica.